Morning Movers 08/10: (FIO) (EPAY) (XIN) Higher; (UBNT) (RNDY) (IMPV) Lower
Tweet Send to a Friend
Get Alerts UBNT Hot Sheet
Down)
Trade UBNT Now!
Ubiquiti Networks (Nasdaq: UBNT) 42.7% LOWER; reported Q4 EPS of $0.30, $0.01 better than the analyst estimate of $0.29. Revenue for the quarter came in at $94.9 million versus the consensus estimate of $94.59 million. Sees Q1 2013 EPS of $0.14-$0.17, versus the consensus of $0.29. Sees Q1 2013 revenue of $62-$70 million, versus the consensus of $98.4 million. Downgraded at Wedbush, Deutsche Bank, Capstone, and Pacific Crest today.
Fusion-io (NYSE: FIO) 28.7% HIGHER; reported Q4 EPS of $0.09, versus $0.15 reported last year. Revenue for the quarter came in at $106.6 million, versus $71.7 million reported last year. Sees Q113 revs up modestly from Q4. Sees FY13 revenue growth in the range of 45 to 50%. For more, click here.
Roundys (NYSE: RNDY) 24.2% LOWER; reported Q2 EPS of $0.42, $0.01 worse than the analyst estimate of $0.43. Revenue for the quarter came in at $996.8 million versus the consensus estimate of $998.13 million. Sees FY2012 EPS of $1.10-$1.24, versus the consensus of $1.34. Downgraded by BB&T, Jefferies, and Credit Suisse.
Bottomline Technologies, Inc. (Nasdaq: EPAY) 20.8% HIGHER; reported Q4 EPS of $0.26, $0.04 better than the analyst estimate of $0.22. Revenue for the quarter came in at $61.4 million versus the consensus estimate of $59.75 million.
Imperva, Inc. (NYSE: IMPV) reported Q2 EPS of ($0.02), $0.03 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $24.6 million versus the consensus estimate of $23.6 million. Sees Q3 2012 revenue of $24.6-$25 million, versus the consensus of $24.7 million. Imperva also sees FY2012 revenue of $99.5-$101.5 million, versus the consensus of $99.1 million.
Codexis, Inc. (Nasdaq: CDXS) 16.8% LOWER; reported Q2 EPS of ($0.15), $0.04 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $22.9 million versus the consensus estimate of $29.84 million.
Xinyuan Real Estate Co. (NYSE: XIN) 16.6% HIGHER; reported Q2 EPS of $0.94, $0.54 better than the analyst estimate of $0.40. Revenue for the quarter came in at $253.1 million versus the consensus estimate of $213.3 million. Sees Q3 2012 revenue of $225-$235 million, versus the consensus of $201.20 million. Sees FY2012 revenue of $825-$845 million, versus the consensus of $771.30 million. Yesterday, August 9, 2012, the Company acquired a parcel of land In Suzhou with a total GFA of approximately 128,000 square meters at a cost of RMB270 million(US$42.6 million).
eMagin Corp. (NYSE: EMAN) 15.3% HIGHER; reported Q2 EPS of $0.02, versus $0.01 reported last year. Revenue for the quarter came in at $8.6 million versus the consensus estimate of $7.4 million.
PharmAthene, Inc. (AMEX: PIP), 14.4% LOWER; received notification from the U.S. Food and Drug Administration (FDA) that its SparVax rPA anthrax vaccine program has been placed on clinical hold. The Agency indicated that the Company will receive a letter providing details of the basis for the clinical hold within 30 days. During this period, PharmAthene will continue to provide the agency with analytical data from its recently produced GMP lot of material. The clinical study, which was expected to begin by the end of this year, has not enrolled any subjects to date and accordingly, there have been no adverse events reported.
51job Inc (Nasdaq: JOBS) 13.1% HIGHER; reported Q2 EPS of $0.66, $0.09 better than the analyst estimate of $0.57. Revenue for the quarter came in at $56.7 million versus the consensus estimate of $55.4 million.
DG FastChannel, Inc. (Nasdaq: DGIT) 13.0% LOWER; reported Q2 EPS of $0.02, $0.09 worse than the analyst estimate of $0.11. Revenue for the quarter came in at $96.3 million versus the consensus estimate of $100.7 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Fusion-io (NYSE: FIO) 28.7% HIGHER; reported Q4 EPS of $0.09, versus $0.15 reported last year. Revenue for the quarter came in at $106.6 million, versus $71.7 million reported last year. Sees Q113 revs up modestly from Q4. Sees FY13 revenue growth in the range of 45 to 50%. For more, click here.
Roundys (NYSE: RNDY) 24.2% LOWER; reported Q2 EPS of $0.42, $0.01 worse than the analyst estimate of $0.43. Revenue for the quarter came in at $996.8 million versus the consensus estimate of $998.13 million. Sees FY2012 EPS of $1.10-$1.24, versus the consensus of $1.34. Downgraded by BB&T, Jefferies, and Credit Suisse.
Bottomline Technologies, Inc. (Nasdaq: EPAY) 20.8% HIGHER; reported Q4 EPS of $0.26, $0.04 better than the analyst estimate of $0.22. Revenue for the quarter came in at $61.4 million versus the consensus estimate of $59.75 million.
Imperva, Inc. (NYSE: IMPV) reported Q2 EPS of ($0.02), $0.03 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $24.6 million versus the consensus estimate of $23.6 million. Sees Q3 2012 revenue of $24.6-$25 million, versus the consensus of $24.7 million. Imperva also sees FY2012 revenue of $99.5-$101.5 million, versus the consensus of $99.1 million.
Codexis, Inc. (Nasdaq: CDXS) 16.8% LOWER; reported Q2 EPS of ($0.15), $0.04 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $22.9 million versus the consensus estimate of $29.84 million.
Xinyuan Real Estate Co. (NYSE: XIN) 16.6% HIGHER; reported Q2 EPS of $0.94, $0.54 better than the analyst estimate of $0.40. Revenue for the quarter came in at $253.1 million versus the consensus estimate of $213.3 million. Sees Q3 2012 revenue of $225-$235 million, versus the consensus of $201.20 million. Sees FY2012 revenue of $825-$845 million, versus the consensus of $771.30 million. Yesterday, August 9, 2012, the Company acquired a parcel of land In Suzhou with a total GFA of approximately 128,000 square meters at a cost of RMB270 million(US$42.6 million).
eMagin Corp. (NYSE: EMAN) 15.3% HIGHER; reported Q2 EPS of $0.02, versus $0.01 reported last year. Revenue for the quarter came in at $8.6 million versus the consensus estimate of $7.4 million.
PharmAthene, Inc. (AMEX: PIP), 14.4% LOWER; received notification from the U.S. Food and Drug Administration (FDA) that its SparVax rPA anthrax vaccine program has been placed on clinical hold. The Agency indicated that the Company will receive a letter providing details of the basis for the clinical hold within 30 days. During this period, PharmAthene will continue to provide the agency with analytical data from its recently produced GMP lot of material. The clinical study, which was expected to begin by the end of this year, has not enrolled any subjects to date and accordingly, there have been no adverse events reported.
51job Inc (Nasdaq: JOBS) 13.1% HIGHER; reported Q2 EPS of $0.66, $0.09 better than the analyst estimate of $0.57. Revenue for the quarter came in at $56.7 million versus the consensus estimate of $55.4 million.
DG FastChannel, Inc. (Nasdaq: DGIT) 13.0% LOWER; reported Q2 EPS of $0.02, $0.09 worse than the analyst estimate of $0.11. Revenue for the quarter came in at $96.3 million versus the consensus estimate of $100.7 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- StreetInsider.com Pre-Open Movers 5/17: (HALO) (ORMP) (CLSN) Higher; (ARUN) (ADSK) (BRCD) Lower (more...)
- UPDATE: Aruba Networks, Inc. (ARUN) Misses Q3 EPS by 4c, Guidance Light
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Credit Suisse, Deutsche Bank, Jefferies & Co, BB&T Capital Markets, Pacific Crest Securities, Morning Movers, Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
